Canada markets open in 2 hours 18 minutes

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.28-0.32 (-5.71%)
At close: 04:00PM EDT
5.34 +0.06 (+1.14%)
After hours: 07:57PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
4,754
3,208
5,408
2,124
6,469
Selling General and Administrative
5,669
11,213
7,605
5,580
5,364
Total Operating Expenses
10,424
14,421
13,013
7,704
11,833
Operating Income or Loss
-10,424
-14,421
-13,013
-7,704
-11,833
Interest Expense
582.537
-
427.542
821.366
516.45
Total Other Income/Expenses Net
-408.4
-93,333
-607.001
441.581
-333.658
Income Before Tax
-11,414
-107,754
-14,048
-8,084
-12,683
Income Tax Expense
-9,456
-9,456
0
0
-
Income from Continuing Operations
-11,414
-98,298
-14,048
-8,084
-12,683
Net Income
-11,414
-98,298
-14,048
-8,084
-12,683
Net Income available to common shareholders
-21,430
-106,246
-24,063
-8,084
-12,683
Basic EPS
-78.43
-
-346.10
-139.88
-183.27
Diluted EPS
-78.43
-
-346.10
-139.88
-183.27
Basic Average Shares
1,243
-
69.205
57.792
69.205
Diluted Average Shares
1,243
-
69.205
57.792
69.205